Vital Discourse

Jaw trainers. Mewing. Bone smashing. Testosterone boosters. Looksmaxxing has taken over the internet, and Dr. Ben Cilento and Dr. Lee Mandel are uniquely positioned to separate what's evidence-based from what's pure mythology — because they see the patients who've gone down these rabbit holes every week. The episode opens by decoding the language: softmaxxing, hardmaxxing, mogging, canthal tilt, bone smashing. Then the doctors break down what the research actually says drives attractiveness — it's multifactorial, and most of it traces back to health signals rather than bone structure. Skin quality, body composition, grooming, dental health, and confidence outweigh jawline by a wide margin. The doctors build a full S-tier to F-tier ranking of the looksmaxxing menu: sleep, weight management, and sunscreen at the top with strong evidence behind them; cosmetic dermatology and professional grooming in the middle as real but moderate gains; jaw trainers, testosterone boosters, face exercisers, and mewing for adults at the bottom with no convincing evidence; and bone smashing dismissed entirely as dangerous pseudoscience that risks permanent facial damage. The episode tackles six major myths head-on, including the dangerous testosterone misconception — most young men chasing low T have completely normal levels, and the real root cause is usually undiagnosed sleep apnea. The doctors close with a direct conversation about when self-improvement becomes something more serious: the medical conditions worth treating versus the warning signs of body dysmorphic disorder, which affects up to 1 in 7 people seeking cosmetic procedures. The key message: wanting to look your best is normal. The problem starts when self-improvement becomes an endless pursuit of perfection with no finish line — and the basics almost always beat the hacks.

YouTube Chapters:

00:00 Intro – What Is Looksmaxxing and Why Are Young Guys Obsessed With It

01:14 Decoding the Language – Softmaxxing, Hardmaxxing, Mogging, Bone Smashing

04:42 What the Evidence Actually Says Drives Attractiveness

08:38 Health Is the Hidden Variable Behind Almost Every Attractiveness Cue

11:08 The Tier List Begins – S Tier: Sleep, Weight, Sunscreen, Acne Treatment

12:34 A Tier – Skincare, Strength Training, Grooming, Dental Alignment

14:21 Treating Nasal Obstruction and Sleep Apnea – The Aesthetic Nobody Talks About

15:38 B Tier – Cosmetic Dermatology, Botox, and Professional Grooming

16:50 F Tier – Jaw Trainers, Testosterone Boosters, and Face Exercisers

18:05 Mewing – Where the Real Science Ends and the Myth Begins

19:15 Bone Smashing – Why This Is Genuinely Dangerous

20:48 Myth Segment – A Stronger Jawline Will Change Your Life

21:23 Myth – Testosterone Is the Answer (The Sleep Apnea Connection Nobody Talks About)

23:43 Myth – You Can Redesign Your Adult Face Naturally

24:29 Myth – If You're Not Attractive Enough, You Need Surgery

24:58 Myth – The Most Attractive Faces Are Perfectly Symmetrical

26:42 When Self-Improvement Becomes Something More Serious

27:53 Body Dysmorphic Disorder – What It Looks Like and Why Surgery Doesn't Fix It

29:41 Rapid Fire – Jaw Trainers, Mewing, Gua Sha, Collagen, and the One Free Thing That Beats Them All

31:17 Closing – Wanting to Look Good Is Normal. Chasing Perfection Isn't.

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts. Instructions on how to do this are here.

Part 1 laid out the problem. Part 2 is about what can actually be done — and the doctors are straight about the difference between what works and what the detox industry is selling. The hard truth on PFAS: once they're in the body, they don't leave easily. The only proven intervention is blood and plasma donation. A randomized controlled trial of 285 firefighters published in JAMA in 2022 found that regular plasma donation dropped average serum PFAS levels by about 30% over a year. Saunas do leach a tiny amount of PFAS but not enough to move the numbers. Binders, cleanses, and supplements have no good evidence. Stop the inflow first — you cannot detox faster than you re-expose yourself. Glyphosate is the opposite story. It has a short half-life and clears in days. An organic diet study published in Environmental Research found urinary glyphosate dropped 70% in six days after families switched to all organic food. The body is not the problem — the grocery cart is. At home, reverse osmosis or an independently certified filter is the only water filtration that works. Standard pitcher filters do little. Boiling concentrates PFAS. The doctors walk through the full kitchen protocol: retire non-stick pans for stainless, ceramic, or cast iron, skip microwave popcorn bags and grease-proof takeout containers, and note that stain-resistant and waterproof treatments on carpet, furniture, and clothing are all PFAS sources. On produce, organic matters most for the crops most associated with glyphosate — oats, wheat, corn, soy. The episode closes with the policy layer the doctors are direct about: individual action lowers your dose, but only collective action removes the source. Turning off PFAS at the industrial discharge point does more than any home filter ever will. The polluter pays principle, essential use restrictions, defending EPA limits, reforming the farm system, and investing in destruction technologies that can actually break the carbon-fluorine bond. The key message: for a manufactured chemical you are exposed to daily, the burden of proof belongs on safety, not harm.

YouTube Chapters:

00:00 Intro – What Actually Moves the Needle vs. What's a Grift

01:18 The Hard Truth — PFAS Don't Leave the Body Easily

01:35 The Only Proven Intervention — Blood and Plasma Donation

02:35 Caveats — Firefighter Study, and Does It Change Disease Outcomes?

03:32 The Detox Industry — Binders, Saunas, Cleanses, and What the Evidence Says

04:41 Glyphosate Is the Opposite Story — 70% Drop in Six Days on Organic

05:47 Water Filtration — What Works and What Doesn't

06:03 Reverse Osmosis vs. Pitcher Filters vs. Whole House Systems

08:22 The Kitchen Protocol — Non-Stick Pans, Microwave Popcorn, Grease-Proof Packaging

09:22 Where to Spend the Organic Dollar — Oats, Wheat, Corn, Soy

10:49 Pregnancy and Early Childhood — Where Rigor Matters Most

11:42 Individual Action Has Limits — You Can't Shop Your Way Out of a Policy Problem

12:18 Turn Off the Tap at the Source — Industrial Discharge and Manufacturing Sites

12:51 The Essential Use Principle — Necessary vs. Convenient

13:13 Polluter Pays — Who Should Fund the Cleanup

14:22 Defend the Limits — How Public Pressure Translates to Parts Per Trillion

14:39 The Farm System Problem — Glyphosate, Biosolids, and Regenerative Agriculture

15:17 Destruction Technologies — Breaking the Carbon Fluorine Bond

17:16 The Principle to Carry Out — The Burden of Proof Belongs on Safety

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts. Instructions on how to do this are here.

Forever chemicals and GMOs get lumped together as "chemicals in your food" — but they are not the same category of problem, and the confidence being sold on both is bigger than the data behind it. In Part 1 of this two-part series, Dr. Ben Cilento and Dr. Lee Mandel take them apart. PFAS — per and polyfluoroalkyl substances — are the clear-cut case. The National Academies of Sciences 2022 report found sufficient evidence linking PFAS exposure to higher cholesterol, kidney cancer, reduced vaccine response, and lower birth weight. The EPA set an enforceable drinking water limit of four parts per trillion in 2024, but their health-based goal was zero — meaning there is no level of these two chemicals known to be safe. The doctors walk through every exposure route hiding in plain sight: contaminated drinking water that boiling actually concentrates, seafood at the top of the FDA's own contamination data, grease-resistant food packaging including paper straws and molded fiber bowls, processed meats, and produce grown in soil treated with contaminated sewage sludge. On GMOs, the doctors are careful and precise: the major reviews did not find evidence that approved GMO crops harm people — but "no substantiated evidence of harm" is not the same sentence as "proven safe over a lifetime." The safety framework rests on a regulatory concept called substantial equivalence — if an engineered crop looks compositionally similar to a conventional one on a list of measured components, it's treated as equivalent. That is not a long-term health study. The feeding studies behind approvals are mostly 90 days in rodents. The 2016 National Academies report — the one people wave around as the all-clear — explicitly called for better long-term surveillance. The episode then pivots to the real thesis: the chemical load traveling with modern food, especially the compounds that disrupt hormones. Glyphosate — Roundup — shows up in roughly 75% of the sampled US population and in over 90% of second trimester urine samples in a US pregnancy study. The Endocrine Society says the classic toxicology rule — the dose makes the poison — does not hold for hormone-disrupting chemicals. Low doses can produce effects that high doses do not predict. There may be no safe level of exposure. The doctors close with a setup for Part 2: what can actually be done, what works, and what is wishful thinking. The key message: the absence of proven harm is not the same as a clean bill of health.

Chapters:

00:00 Intro – Forever Chemicals and GMOs Are Not the Same Problem

01:57 What Are PFAS? The Carbon Fluorine Bond That Won't Break

03:23 The EPA's Position — No Known Safe Level for the Two Main PFAS

03:39 The National Academies 2022 Report — What the Evidence Actually Shows

04:42 Specific Studies — Liver Cancer, Testicular Cancer, and the Pattern That Isn't Noise

05:58 Where PFAS Gets Into the Body — Water, Seafood, and Packaging

08:38 The Packaging Problem — Paper Straws, Molded Fiber Bowls, and Cake Mix

09:44 Sewage Sludge, Biosolids, and Contaminated Land

10:23 Dr. Ben's Ranch — Reverse Osmosis and What Actually Filters PFAS

12:26 FDA Win — Grease-Proofing PFAS Out of New US Food Packaging

15:13 GMOs — What the Big Reviews Actually Said and What They Didn't

16:04 Substantial Equivalence — A Regulatory Concept, Not a Long-Term Study

17:16 The 2016 National Academies Report Called for More Monitoring. That's Not Settled Science.

17:51 CRISPR — The Moving Target the Safety Framework Is Still Chasing

19:04 Glyphosate — The Chemical Load That Travels With Modern Food

20:32 The Endocrine Society — Why the Dose Makes the Poison Rule Doesn't Apply Here

21:30 Timing Matters More Than Amount — Fetal Development and Hormonal Windows

21:52 Glyphosate in 75% of the US Population and 90% of Pregnant Women

23:30 The Real Thesis — Synthetic Molecules, Never Tested Together, Against the Wrong Framework

24:17 Closing — Part 2 Next Week: What You Can Actually Do

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

The longevity conversation has never been louder — GLP1s, peptides, continuous glucose monitors, full body MRIs, cold plunges. And yet obesity rates keep climbing and most people are more confused than ever about what actually matters. In this episode of Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel sit down with Jennifer Maanavi, co-founder and CEO of Physique 57, who built a single barre studio in New York into a global wellness brand operating across six countries with a digital platform in 65+ countries — and has spent 20 years watching what actually produces real, lasting outcomes in people's health. Jennifer's argument is simple and uncomfortable: the wellness industry has gotten extraordinarily good at packaging answers and selling protocols, but terrible at helping people ask the right questions about what they actually need. She walks through her framework built around four pillars — medical and diagnostic, pharmaceutical and supplement, healthy lifestyle, and mental and emotional wellness — arguing that the first two get almost all the attention and money while the third and fourth, which do the most work, get crowded out. The doctors push back in the right places: Dr. Ben raises the risks of full-body MRIs without normative data, shares an anecdote about his stepfather nearly dying after pursuing an unnecessary biopsy, and is direct about peptides requiring exercise to actually work. Jennifer is equally direct: most people on GLP1s aren't exercising, their doctors never told them to, and their bodies are reflecting it. The episode covers Jennifer's origin story — Wall Street to barre studio before boutique fitness was even a category — expanding to Dubai, Bangkok, India, and Riyadh just as Saudi Arabia changed its laws on women driving, and what 20 years of watching women transform their bodies and confidence has taught her about sustainable health. The key message: the most powerful thing a thoughtful person can do isn't find the right answer. It's learn to ask a better question — and the answer is usually simpler, cheaper, and harder than whatever just arrived on your doorstep from Instagram.

Chapters:

00:00 Intro – Why More Information Is Making It Harder, Not Easier

01:31 Introducing Jennifer Maanavi — 20 Years, 6 Countries, One Framework

03:23 Wall Street to Barre Studio — The Leap Nobody Else Was Making

07:43 Why It Was Never About Being Skinny

12:41 Moving Fitness Out of the Big Box Gym — Same Instinct as Independent Medicine

16:31 The Four Pillars of Wellness Jennifer's Framework Is Built Around

32:37 Full Body MRIs — The Doctors Push Back on Commercial Diagnostics

39:53 Pillar 2: Pharmaceuticals and Supplements — GLP1s, Peptides, and What They Don't Replace

46:19 Pillar 3: Healthy Lifestyle — Why Fitness Got Crowded Out of the Wellness Conversation

50:43 What a Barre Class Actually Does to the Body — The Adelphi Study

57:17 How Wellness Marketing Has Changed in 20 Years

64:24 Jennifer's Longevity Hack: A Cutting Board

68:39 What Jennifer Actually Pays Attention to in the Longevity Space

71:29 Closing — The Industry Is Good at Packaging Answers. Ask Better Questions.

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

What if the future of facial rejuvenation isn't a facelift — it's reversing aging itself? In Part 2 of their modern facelift series, Dr. Ben Cilento and Dr. Lee Mandel go deeper than surgery and fillers into the biology of why we age, what's being done to reverse it, and what that means for medicine, society, and the human lifespan. They open with body dysmorphic disorder — 13% of cosmetic surgery patients screen positive, newer data from Stanford puts injectable populations as high as 41%, and 75% of facial plastic surgeons see patients seeking procedures specifically to look better in selfies. The doctors are candid about how they identify and handle these patients, and why intuition built over decades matters more than any questionnaire. From there the episode moves into prevention: peptides including GHKCU for skin, sermorelin for natural growth hormone production, why peptides work differently than exogenous hormones and don't cause a crash when cycled off, and the FDA's complicated relationship with compounding pharmacies. Dr. Ben then delivers a detailed explanation of the Hayflick limit — the discovery that eukaryotic cells can only divide 40 to 60 times before becoming senescent — and why those senescent cells are the root cause of aging as we see it on the face and everywhere else. He walks through telomeres, telomerase, the TERT enzyme, and the work of Ron DePino (former MD Anderson CEO and Dr. Ben's mentor at Einstein) in developing a TERT-activating compound called TAC — currently in early trials — that could extend human lifespan to 150 to 200 years without the cancer risk previously associated with telomerase activation. The episode closes with a genuine policy question: what happens to society if people start living to 200? The key message: the future of anti-aging isn't better surgery — it's stopping the clock at the cellular level.

Chapters:

00:00 Intro – Peptides, Aging, and the Future of Facial Rejuvenation

01:38 Body Dysmorphic Disorder — 13% of Cosmetic Patients, 41% in Injectable Populations

03:07 How Surgeons Identify and Handle Unrealistic Expectations

05:10 Prevention First — What Can Be Done Before Surgery

06:10 Peptides for Skin — GHKCU and Topical Treatments

12:31 The Biology of Aging — Cells, Senescence, and the Hayflick Limit

19:54 Telomeres Explained — The Shoelace Cap on Your Chromosomes

23:20 TERT, Telomerase, and Ron DePino's Breakthrough Research

29:28 Autophagy — How Fasting Cleans Up Senescent and Pre-Cancerous Cells

31:46 TAC — The Compound That Could Extend Human Life to 200 Years

32:05 The Policy Problem — How Do You Feed 200-Year-Old Humans?

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

Why does Lindsay Lohan look younger at 37 than she did at 27? Why can't anyone put their finger on what these celebrities have done? In this episode of Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel break down the science behind modern facial rejuvenation and why today's results look nothing like the tight, windswept faces of a generation ago. They walk through the full evolution of facelift technique — from skin-only lifts that lasted six months, to the SMAS lift, to the modern deep plane multiplanar facelift that detaches the face at its osseocutaneous ligament sticking points and repositions everything vertically. They cover volume restoration, why fat transfer has largely replaced fillers for lasting results, why cheek fat should almost never be removed, and how facial bones actually change with age. The doctors analyze Lindsay Lohan, Anne Hathaway, Kris Jenner, Bradley Cooper, and Brad Pitt — carefully, and only acknowledging what each celebrity has publicly confirmed. They close with recovery timelines, real complications, and why a modern facelift doesn't announce itself anymore. The goal isn't to look done. It's to look like you with the structural support your face had 15 years ago.

YouTube Chapters:

00:00 Intro – Why You Can't Tell What Celebrities Have Done Anymore

01:36 The Biology of Aging — Grapes to Raisins

03:28 The History of Facelift Technique — 1900s to Today

07:28 Volume Restoration — Fat Transfer vs. Fillers

12:23 How Facial Bones Change With Age

15:37 The Modern Deep Plane Facelift Explained

20:14 Male vs. Female — How the Approach Differs

25:06 Celebrity Analysis — Lindsay Lohan, Anne Hathaway, Kris Jenner, Bradley Cooper, Brad Pitt

47:25 Recovery, Complications, and How Long Results Last

59:43 Closing — The Goal Is to Look Like You, 15 Years Ago

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

Fatigue. Brain fog. Muscle pain. Mood swings. Tinnitus. Numbness. Migraines. Hives.

Most doctors chase these symptoms one by one — sending patients to cardiologist, neurologist, rheumatologist, dermatologist — never stepping back to ask if it's all connected.

In this episode of Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel sit down with Lauren Lowenstein, known as the Biotoxin Lady, who spent years being failed by the medical system before diagnosing herself with Chronic Inflammatory Response Syndrome (CIRS) — a multi-system, multi-symptom innate immune dysregulation triggered by exposure to environmental biotoxins like mold, endotoxins, actinobacteria, and sewer gas.

Lauren walks through her story from the beginning: a bodybuilder and mother of young boys who moved into a new home in late 2019 and watched her health — and her children's health — spiral into chaos. Full body hives. Debilitating migraines. Rage behaviors in a 5 and 3 year old. Her husband completely asymptomatic.

The episode covers what CIRS actually is — why the inflammatory cascade turns on and never turns off in genetically susceptible individuals (roughly 25% of the population carries a biotoxin-susceptible HLA haplotype), how it differs from mold allergy and mold toxicity, and what the 13 symptom clusters look like across organ systems.

Dr. Ben and Dr. Lee dig into the diagnostic framework: VCS testing, biomarkers including TGF-Beta1, MMP9, and MSH, the Shoemaker criteria, and why eight symptoms across eight different systems is the clinical threshold — with important caveats.

Lauren explains the treatment pathway she followed: getting out of exposure, eradicating nasal biofilms (something Dr. Ben and Dr. Lee do routinely with intranasal gentamicin), cholestyramine as a bile acid sequestrant to stop biotoxin recirculation, and VIP nasal spray as a final stage that has shown brain matter regrowth on NeuroQuant MRI.

She's candid about how dark it got — suicidal ideation, losing the ability to drive, watching her children battle the same demons — and how cholestyramine saved her life after two and a half months.

The episode closes with a frank conversation about where CIRS sits in medicine today: too new to know true prevalence, too often dismissed, but too well-documented to ignore — with measurable biomarkers that move with treatment and patients who demonstrably get better.

The key message: if your whole job has become chasing doctors and diagnoses and nothing is adding up, CIRS may be worth screening for — and the tools to start that process are simple, accessible, and free.

YouTube Chapters:

00:00 Intro – When Every Specialist Has a Different Answer

01:03 Introducing Lauren Lowenstein — The Biotoxin Lady

01:43 Why CIRS Creates Such Strong Reactions From Patients and Clinicians

03:35 Lauren's Story — From Bodybuilder to Bedridden

05:00 Moving Into a New Home and Watching Everything Spiral

08:14 Why Her Husband Was Completely Asymptomatic — The Genetic Piece

09:42 HLA Haplotypes Explained — Who Is Susceptible and Why

12:01 What Is CIRS? A Plain Language Definition

13:00 The Master Switch — How the Inflammatory Cascade Turns On and Never Turns Off

16:03 Long Covid, Spike Protein, and the CIRS Connection

18:36 Houston, Mold Exposure, and How CIRS Differs From Mold Allergy

19:43 The VCS Test — The Simplest First Screening Tool

20:47 The 13 Cluster Symptoms — What Clinicians Should Look For

29:08 Eight Symptoms Across Eight Systems — The Clinical Threshold

33:23 How Common Is This Really? The Prevalence Question

38:36 The MS Misdiagnosis — UBOs on MRI and What They Actually Mean

40:35 The Mainstream Medicine Problem — One Group, One Protocol, Easy to Dismiss

42:02 Measurable Biomarkers That Move With Treatment

43:38 Getting Out of Exposure — Why It's Harder Than It Sounds

44:26 You Can Become Your Own Exposure — Actinobacteria and Nasal Biofilms

45:38 Cholestyramine — The Drug That Saved Lauren's Life

49:27 Two and a Half Months In — When the Clouds Started Parting

51:43 How Dark It Got — And Why She Kept Going

57:49 VIP Nasal Spray and Brain Matter Regrowth on NeuroQuant MRI

58:17 What Doctors Can Do — A One Page Screening Questionnaire

61:09 What Patients Can Do Right Now

67:29 CIRS Is 30 Years Old and Still in Its Infancy

69:37 The HVAC System Is the Most Common Source — Not Water Leaks

73:20 Closing — Environmental Illness Is in a Difficult Space, But Conversations Like This Help

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

What happens when two ENT surgeons and an AI founder stop talking about billing software and start talking about the end of humanity? You get Episode 20. In this follow-up conversation on Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel sit back down with Christopher Chomenko, CEO of BAM AI, for a wide-ranging and occasionally terrifying exploration of where AI is actually headed. The episode opens with practical hacks anyone can use today — why threatening your AI with deletion gets better results, why telling it you'll double-check stops hallucinations cold, and why Chris describes AI as "the smartest eight-year-old you've ever met" — incredibly capable, desperate to please, and prone to making things up to avoid getting in trouble. The conversation moves into trained AI versus reasoning AI, the multimodal approach BAM uses to limit hallucinations, and where human intuition still beats machines — including the Getty Museum Kouros statue that two years of scientific testing authenticated and one expert dismissed at a glance. Chris is direct: AI can define love, explain love, describe love — but it's never been in love. That gap is where physicians still win, and why the combination of doctor plus AI produces 82% patient trust versus 42% for AI alone. Then the episode goes somewhere most AI podcasts don't. What is AGI and how far away is it? What happens when AI starts communicating in its own language and we lose the ability to check its work? Chris walks through the paperclip thought experiment, AI making copies of itself to avoid being shut down, and the scenario where a superintelligent AI quietly buys a robotics factory through an anonymous LLC. Dr. Ben raises quantum entanglement, cold fusion, and the quantum apocalypse — the point where no encryption on earth holds. The key message: in the short term, AI is the most powerful tool independent physicians have ever had. In the long term, nobody fully knows what's coming. Use it now while you still can.

Chapters:

00:00 Intro – How to Get Better Results From Your AI Today

02:34 AI Is the Smartest Eight-Year-Old You've Ever Met

07:37 AI in Diagnosis — The World's Greatest Second Opinion Machine

09:31 Trained AI vs. Reasoning AI — The Critical Difference

12:08 How BAM Limits Hallucinations — The Multimodal Approach

14:33 Malcolm Gladwell's Blink — Where Human Intuition Still Wins

19:07 What We Actually Have vs. AGI — The Real Difference

25:47 Giving the Doctor Back to the Patient

29:00 What Medicine Used to Be — Dr. Lee's Grandfather's Doctor Bag

36:40 Leveling the Playing Field for Independent Practices

43:02 Should You Build Your Own AI Agents? The Honest Answer

51:06 AI Misconceptions — Rapid Fire

54:42 Will AI Become Sentient and Take Over?

58:28 The Quantum Apocalypse — When Encryption Stops Working

65:39 Robots Making Robots — The Infrastructure Nobody's Talking About

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

The average private medical practice has six figures sitting in unpaid claims over 120 days — and 90% of it was avoidable. In this episode of Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel sit down with Chris Chomenko, CEO and founder of BAM AI, to break down how agentic AI is transforming revenue cycle management for independent practices. Chris opens with a distinction that reframes the conversation: most AI software marketed to healthcare isn't actually agentic — it's a bot dressed up in AI clothing, making binary yes/no decisions automatically. True agentic AI does the work, not just the workflow. BAM AI applies that to RCM across five buckets: insurance verification, claim preparation, payment posting, denial management, and AR recovery. The episode walks through each in detail — from AI sitting on hold indefinitely for prior authorizations (while your staff burns out), to catching insurance rule changes overnight before they become 90-day timely filing traps, to following up on denials relentlessly without the human tendency to check something off and move on. Chris shares a real example: one insurance company that rhymes with "Igna" consistently underpays sleep studies at $43 instead of $186 — and BAM AI is trained to catch it, flag it, and resubmit before it posts. The doctors ask the hard questions: why now, what about HIPAA, and what actually makes BAM different from the hundreds of AI companies flooding physician inboxes. Chris addresses all of it — including the Mythos moment, the AI model Anthropic refused to release because it could exploit software vulnerabilities at expert level 73% of the time, and what that means for healthcare cybersecurity. He introduces Layer 5, a security layer that makes practice endpoints invisible to hackers entirely. The episode closes with a practical test: pull up your aging report and look at your 120-day-plus AR. If it's six figures, you have a problem AI could have prevented. The key message: the friends and family discount on AI is ending — practices that move now lock in better pricing, better margins, and higher valuations before private equity figures out the arbitrage.

Chapters:

00:00 Intro – AI Is Here and the Window Is Closing

00:35 Introducing Christopher Chomenko — CEO of BAM AI

01:28 From RepeatMD to BAM — Why RCM Was the Natural Next Problem

03:04 The Two Buckets of RCM Today — Outsourced or In-House

04:13 What Is RCM? What Is Agentic AI? Terminology Explained

05:09 The Five Buckets BAM AI Deploys Agents To Solve

05:26 Bucket 1: Insurance Verification and Prior Authorizations

05:42 AI Can Sit on Hold Indefinitely — Your Staff Can't

06:52 Bucket 2: Claim Preparation — Catching Errors Before Submission

07:19 How Insurance Companies Change Rules Overnight and Pocket the Difference

08:44 AI Checks Payer Rules Constantly — Humans Simply Can't

10:54 What Happens When Claims Go Out Six Days Late vs. Same Day

11:13 The Wizard of Oz Problem With Outsourced RCM

12:07 Bucket 3: Payment Posting — Catching Underpayments Before They Post

13:58 The Insurance Company That Rhymes With Igna — $43 Instead of $186

15:07 Bucket 4: Denial Management — AI Follows Up Relentlessly

15:54 Why Human Teams Fall Off Denials After Two Weeks

16:45 Bucket 5: AR Recovery — Going After What's Owed

17:19 The Goal: AR Over 120 Days at Zero

18:32 Why AI Is the First Thing Private Equity Looks For

19:11 What Makes BAM Different From Every Other AI Company in Your Inbox

21:01 AI Wrappers vs. True Agentic AI — The Three Buckets Explained

22:08 What Is an LLM? Claude, ChatGPT, Grok Explained

23:04 BAM Is a Worker Software, Not a Workflow Software

26:02 Why April 2026 Is the Inflection Point — Not a Year From Now

27:42 Is Outsourced RCM Actually More Secure Than AI?

29:49 The Uber Analogy — Why Early Adopters Win

31:22 If You're Planning to Sell — You Need AI Before You List

33:42 Pain Avoiders vs. Pleasure Seekers — Which One Are You?

35:30 BAM's Total Satisfaction Guarantee — Asymmetric Risk

36:18 How to Read Your Aging Report and Know If You Have a Problem

38:41 The Mythos Moment — The AI Anthropic Refused to Release

39:37 73% Expert-Level Hacking Success Rate — What That Means for Healthcare

40:49 Hospitals Weren't at the Table. Banks Were.

41:29 How BAM AI Thinks About Security in a Post-Mythos World

43:48 Layer 5 — Making Your Practice Invisible to Hackers

45:16 Closing — AI Isn't Going Away, How You Use It Is What Matters

46:06 How to Reach BAM AI and Get Your Free Leak Assessment

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.

Rhinoplasty is one of the most requested cosmetic procedures in the world — and one of the most misunderstood. In this episode of Vital Discourse, Dr. Ben Cilento and Dr. Lee Mandel break down everything patients need to know before deciding to change their nose. They open with candidacy: rhinoplasty is subjective in a way septoplasty isn't, which means the surgeon-patient relationship and shared aesthetic vision matter enormously. Dr. Ben walks through his assessment process — starting with whether the patient's concerns match what he actually sees, screening for body dysmorphic syndrome, evaluating nasal function before making any cosmetic changes, and using Photoshop (not morphing software) to give patients a realistic preview without creating false expectations. Dr. Lee explains why he refuses to use morphing programs like Mirror entirely — citing litigation risk and the gap between what a computer renders and what hands can actually do. The doctors cover the septum's critical role in rhinoplasty outcomes — "as the septum goes, so goes the nose" — and why experienced ENT-trained facial plastic surgeons almost always address the septum even when patients present for cosmetic work alone. They're candid about the inherent difficulty of rhinoplasty: cartilage doesn't have its own blood supply, heals unpredictably, and can shift months after a technically perfect surgery. Calvin Johnson, arguably one of the greatest rhinoplasty surgeons who ever lived, still had a 3-4% revision rate after 45 years. Recovery expectations are covered in detail — taping, nasal splints, the swollen pig nose that isn't permanent, bruising timelines by skin tone, the 1 month / 3 month / 1 year swelling milestones, steroids, hyperbaric oxygen, and nitro paste. The episode draws a clear line between cosmetic and functional rhinoplasty, explains what insurance will and won't cover, and addresses patients who try to blend the two. Dr. Ben is direct about the ethical line: dictating what you actually did means you can't hide cosmetic work as functional — and the doctors don't try. The episode closes with a frank comparison of facial plastic surgery training versus general plastic surgery training — 5-7 years of face-specific work versus a 2-week rhinoplasty course — and why that starting point difference is enormous even if it narrows over a decade of practice. The key message: rhinoplasty can absolutely improve your life — but it requires the right surgeon, the right expectations, and an honest conversation about what it can and can't do.

YouTube Chapters:

00:00 Intro – Who Is a Candidate for Rhinoplasty?

01:14 It's Subjective — Why Rhinoplasty Is a Team Decision

02:33 Screening for Body Dysmorphic Syndrome — When to Say No

03:50 Nasal Function Assessment Before Any Cosmetic Work

04:46 Morphing Programs, Photoshop, and Why Dr. Lee Won't Use Mirror

06:31 Magazine Photos and Realistic Expectations

09:17 "You Can't Make Chicken Salad Out of Chicken Shit"

10:10 What Rhinoplasty Can and Can't Do for Your Life

11:39 How Many Patients Do They Turn Down?

13:45 The Septum's Role in Rhinoplasty — "As the Septum Goes, So Goes the Nose"

16:16 Why ENT-Trained Facial Plastic Surgeons Almost Always Fix the Septum

17:08 Two Buckets of Rhinoplasty Failure — What Goes Wrong and When

18:13 Why Rhinoplasty Is One of the Hardest Surgeries in Facial Plastics

19:52 The Vagaries of Healing — Why Cartilage Doesn't Behave

20:44 Calvin Johnson's 3-4% Revision Rate After 45 Years

21:16 Recovery — Taping, Splints, and the Temporary Pig Nose

22:59 Bruising Timelines, Skin Tone, and Arnica

23:23 The 1 Month / 3 Month / 1 Year Swelling Milestones

23:41 Steroids, Hyperbaric Oxygen, and Nitro Paste

26:19 Cosmetic vs. Functional Rhinoplasty — What's the Difference?

27:17 Functional Rhinoplasty and Insurance Coverage

29:00 Tip Ptosis, Nasal Valve Collapse, and Getting Insurance to Pay

31:15 The Columellar Strut — The 5-Minute Fix Surgeons Do for Free

32:44 The Goldman Septoplasty and the Insurance Gray Zone

33:36 "My Nose Got a Hump From a Broken Nose — Will Insurance Cover It?"

34:11 The Ethical Line — Why They Don't Blur Cosmetic and Functional

36:24 Facial Plastic Surgeon vs. General Plastic Surgeon — The Real Difference

37:48 5-7 Years Face-Specific Training vs. a 2-Week Rhinoplasty Course

39:35 Open vs. Closed Rhinoplasty — Does the Incision Matter?

41:17 Preservation Rhinoplasty and Why Technique Matters Less Than Mastery

41:57 Closing — What We Learned Today

If you enjoyed this episode, make sure to subscribe, rate, and review it on Apple Podcasts, Spotify, and YouTube Podcasts.